Purchase Order 75N90026P00061
- Not listed
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc. The contract is for the delivery of next-generation sequencing (NGS) reagent kits, valued at $279,096.00, with an ultimate completion date of August 31, 2025. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Caredx Lab Solutions is a leading provider of genomics-based solutions for transplant...
- This contract, awarded by the National Institutes of Health (NIH) Clinical Center to CareDx Lab Solutions Inc., provides ALLOSEQ TX17 KITS, FREIGHT, DRY ICE AND GEL PACKS for the NIH's Department of Transfusion Medicine. The $77,500.00 firm fixed-price purchase order has a period of performance from August 1, 2021 to July 31, 2022. CareDx Lab Solutions Inc. is a subsidiary of the parent company CareDx, Inc., a for-profit organization specializing in advanced medical testing products and services...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide Next Generation Sequencing (NGS) reagents. The $169,560 contract is to support genomic analysis and testing for personalized medicine research at the NIH Clinical Center. Caredx Lab Solutions has previously provided NGS reagent kits and other organ transplant testing products and services to...
- Caredx Lab Solutions Inc. has been awarded a firm fixed price purchase order from the National Institutes of Health Clinical Center valued at two hundred forty-three thousand four hundred eighty dollars ($243,480) to provide next generation sequencing reagent kits. As a subsidiary of Caredx, Inc., Caredx Lab Solutions will supply the specialized molecular testing products to support the agency's genomic analysis research for personalized medicine. No set-aside was utilized for this...
- This federal contract award to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., was made by the National Institutes of Health (NIH) Clinical Center. The $4,936.40 firm fixed-price purchase order was awarded on March 23, 2018, with a completion date of April 22, 2018. The contract does not have a set-aside designation. Caredx Lab Solutions is a provider of genomics-based solutions for transplant patients, specializing in molecular testing services, diagnostic kits, and related products....
- This federal contract award is to Caredx Lab Solutions Inc., a for-profit organization and manufacturer of goods that specializes in genomics-based solutions for transplant patients. The contract, valued at $90,932.49, is a firm fixed-price purchase order for laboratory supplies from the Defense Health Agency, a defense agency. The award is not associated with a set-aside designation, indicating Caredx Lab Solutions Inc. competed for the contract based on its technical capabilities and expertise...
- The Department of the Navy's Bureau of Medicine and Surgery awarded a $149,990 firm fixed-price purchase order to Caredx Lab Solutions Inc. on September 22, 2023, for DR & I technician time services, with performance completed by January 21, 2024. The work was performed at the contractor's facility in West Chester, Pennsylvania. Caredx Lab Solutions, a subsidiary of Caredx, Inc., specializes in genomics-based diagnostic solutions for transplant patients, with particular expertise in...
- CareDx Lab Solutions Inc., headquartered in West Chester, Pennsylvania, was awarded a delivery order valued at $23,972.68 by the Department of Veterans Affairs Veterans Integrated Service Network 17 (VISN 17) on June 3, 2024. This firm fixed-price contract, which carries no set-aside designation, represents a delivery order issued against an existing single-award indefinite delivery contract valued at $787,000 with an ultimate completion date of June 2, 2027. The delivery order calls for the...
- This is a $120,000.00 firm fixed price purchase order awarded by the Department of Health and Human Services, Centers for Disease Control and Prevention, to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc. The contract is for the provision of next generation sequencing reagents, testing kits, and testing services to support the CDC's Pittsburgh operations in Chamblee, Georgia. Caredx is a for-profit company that provides specialized molecular testing products and services, particularly...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,040.00 firm fixed price purchase order to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc. The contract is for the delivery of 7 ASTX17.1(96)-B-RUO KITS, with a completion date of August 30, 2023. Caredx, Inc. is a for-profit company that provides kidney care solutions, including specialized testing kits and services related to organ transplant patients. The company has previously...
The National Institutes of Health Clinical Center awarded a $292,973 firm fixed-price purchase order to CareDx Lab Solutions Inc. for AlloSeq TX17 next-generation sequencing (NGS) reagent kits, with an ultimate completion date of September 30, 2026. CareDx Lab Solutions, a genomics-based diagnostic solutions manufacturer headquartered in West Chester, Pennsylvania, specializes in molecular testing and NGS technologies for organ transplant patients. This award represents the latest in a series of contracts between the NIH Clinical Center and CareDx Lab Solutions, reflecting the agency's continued reliance on the company's specialized diagnostic capabilities for transplant surveillance and rejection risk assessment research initiatives. No set-aside designation was used in this competitive award. CareDx Lab Solutions has established itself as a trusted federal contractor through multiple engagements across the NIH, Department of Veterans Affairs, Department of the Navy, and Centers for Disease Control and Prevention. The company's expertise in transplant diagnostics, particularly its FDA-approved AlloMap molecular testing service, has positioned it as the sole provider for certain specialized genomic testing applications within federal healthcare systems. Prior awards to the company have ranged from approximately $6,480 to $279,096, with the NIH Clinical Center having contracted for similar NGS reagent kits on multiple occasions between November 2022 and November 2024, demonstrating consistent utilization and satisfaction with CareDx Lab Solutions' products and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $293.0k | 1/16/26 |